STL deepens partnership with Netomnia to accelerate the UK’s future-ready full-fibre rollout

End-to-end FTTH solutions from advanced optical fibre cables to high-performance connectivity to speed rollout and lower total cost of ownership STL (NSE: STLTECH), a leading optical and digital solutions company, has expanded its long-standing partnership with Netomnia, the UK's second-largest alternative network provider (Alt-Net). Together, the companies co-develop advanced optical solutions that underpin Netomnia's capitalefficient, […]

D-Link Launches New Wi-Fi 7 Dual-Band Routers

Delivering Faster and Reliable Connectivity for the Next Generation of Smart Homes D-Link Corporation (TWSE: 2332), one of the global leaders in networking solutions, today announced the launch of its latest Wi-Fi 7 routers: the AQUILA PRO AI M36 BE3600 Wi-Fi 7 Smart Mesh Router and the AQUILA PRO AI R36 BE3600 Wi-Fi 7 Smart

Ask.Legal — Legal AI Built in Hong Kong Without Funding, Revolutionizing Legal Services

In a legal tech industry dominated by unicorns and billion-dollar ventures, one Hong Kong startup is rewriting the rules.Ask.Legal, developed by DocPro Limited(a Cyberport and HKSTP incubatee), is a secure, cost-effective, and highly accurate AI legal assistant- created entirely without external funding. Much like DeepSeek, Ask.Legal proves that groundbreaking AI can be built with limited

Uxin Announces Grand Opening of Zhengzhou Used Car Superstore

Uxin Limited (“Uxin” or the “Company”) (Nasdaq: UXIN), China's leading used car retailer, today announced that its new used car superstore in Zhengzhou, Henan Province will officially open on September 27, 2025. The Zhengzhou used car superstore has a gross floor area of approximately 150,000 square meters, integrating one of China's largest used-car showrooms with

Ask.Legal — Legal AI Built in Hong Kong Without Funding, Revolutionizing Legal Services

In a legal tech industry dominated by unicorns and billion-dollar ventures, one Hong Kong startup is rewriting the rules.Ask.Legal, developed by DocPro Limited(a Cyberport and HKSTP incubatee), is a secure, cost-effective, and highly accurate AI legal assistant- created entirely without external funding. Much like DeepSeek, Ask.Legal proves that groundbreaking AI can be built with limited

Norsk Hydro: Hydro’s third quarter results 2025

(Irish:IRSH),(Oslo Bors:NHY77),(Oslo Bors:NHY),(Oslo Bors:NHY78),(Oslo Bors:NHY01),(OTC US:NHYDY),(OTCQX:NHYDY),(Irish:IRSH), Hydro's third quarter results 2025 will be released at 07:00 CEST (01:00 EDT, 06:00 BST, 05:00 UTC/GMT) on October 24, 2025. The quarterly report and presentation will be available on hydro.com at the same time as the release. President and CEO Eivind Kallevik and Executive Vice President and CFO Trond Olaf

Norsk Hydro: Hydro’s third quarter results 2025

Hydro’s third quarter results 2025 will be released at 07:00 CEST (01:00 EDT, 06:00 BST, 05:00 UTC/GMT) on October 24, 2025. The quarterly report and presentation will be available onâ?¯hydro.comâ?¯at the same time as the release. President and CEO Eivind Kallevik and Executive Vice President and CFO Trond Olaf Christophersen, will host a webinar in

Norsk Hydro: Hydro’s third quarter results 2025

Norsk Hydro: Hydro's third quarter results 2025 GlobeNewswire September 26, 2025 Hydro's third quarter results 2025 will be released at 07:00 CEST (01:00 EDT, 06:00 BST, 05:00 UTC/GMT) on October 24, 2025. The quarterly report and presentation will be available on hydro.com at the same time as the release. President and CEO Eivind Kallevik and Executive Vice

Mesoblast Cell Therapy Products are Designated U.S. Origin and Not Subject to Tariffs

(AUST:MSB.AX),(NASDAQ:MESO), NEW YORK, Sept. 26, 2025 (GLOBE NEWSWIRE) — Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today reiterated that its allogeneic cell therapy products are manufactured from U.S. donors in the U.S. and designated as U.S. origin products not subject to tariffs on imported branded or patented pharmaceutical products.

Mesoblast Cell Therapy Products are Designated U.S. Origin and Not Subject to Tariffs

Mesoblast Cell Therapy Products are Designated U.S. Origin and Not Subject to Tariffs GlobeNewswire September 26, 2025 NEW YORK, Sept. 26, 2025 (GLOBE NEWSWIRE) — Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today reiterated that its allogeneic cell therapy products are manufactured from U.S. donors in the U.S. and

Scroll to Top